Some startling facts:
- Prescription drug spending in the US reached a whopping $329.2 billion in 2013.
- In 2011, 4.02 billion prescriptions were written in the US, with more than half of Americans on two prescription drugs.
- Drug side effects are a leading cause of death in hospitals and may be the leading cause of death outside hospitals.
- 100% of patients suffer unintended effects from their prescriptions.
- The annual cost of drug side effects is estimated to be considerably more than $100 billion, yet comprehensive, relevant data necessary to manage a solution is not collected.
- More than 95% of drug side effects go unreported, and there are serious gaps and delays in getting relevant feedback on effects of pharmaceuticals once they are released to the market.
- Regulators do not have reporting systems geared to capturing the data needed for effective post-market monitoring.
The way we see it, there are two real problems here:
- There is a lopsided relationship between vulnerable patients and their doctors who have extraordinary power and knowledge over them.
- The systems and organizations we all rely on to keep us safe are fundamentally broken.
Making medicines safer for all of us.
RxISK is owned and operated by Data Based Medicine Americas Ltd. (DBM), based in Toronto, Canada.
It is run by a group of high-profile medical experts with international reputations in early drug-side-effect detection and risk mitigation, pharmacovigilance, and patient-centered care.
RxISK was launched in October 2012 with the goals of:
- Educating and empowering patients to have better conversations about their meds with their doctors.
- Collecting data on the unintended consequences of prescription medications so that we can draw attention to them.
Other DBM related sites include: